Yulin Li
Molecular Biology · with Felsher · 2014–2016
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 27 citations into it
- Oncology — 25 citations into it
Whom Yulin Li trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Yulin Li's perspective
Ordered by how strongly the researchers Yulin Li trusts endorse each paper. Same corpus, a different order for every researcher.
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC (Science)
- Addiction to Oncogenes--the Achilles Heal of Cancer (Science)
- Modelling Myc inhibition as a cancer therapy (Nature)
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction (Proceedings of the National Academy of Sciences of the United States of America)
- BET bromodomain inhibition as a therapeutic strategy to target c-Myc (Cell)
- Does the ribosome translate cancer? (Nature Reviews. Cancer)
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction (Cell)
- Immunity, Inflammation, and Cancer (Cell)
- c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. (Molecules and Cells)
Their papers
- MYC Regulates the Anti-Tumor Immune Response through CD47 and PD-L1 (2016) — 1,260 citations
- MYC activation is a hallmark of cancer initiation and maintenance. (2014) — 761 citations